Drug Profile
Alpha-synuclein picobody - ICB International
Alternative Names: a-syn-picoLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator ICB International
- Developer Centre de recherche du Centre hospitalier universitaire de Sherbrooke; ICB International
- Class Antibodies; Antibody diagnostics; Imaging agents
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Parkinson's disease
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Parkinson's-disease(Diagnosis) in Canada (Parenteral, Injection)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Parkinson's-disease(Diagnosis) in USA (Parenteral, Injection)
- 07 Jul 2016 Preclinical development is ongoing in USA and Canada